Ultralife Corporation Reports Second Quarter Results
Ultralife Corporation (NASDAQ: ULBI) reported Q2 2026 results for the quarter ended June 30. Sales fell to $47.9 million from $48.6 million in Q2 2025. Gross profit rose to $13.9 million, with gross margin 28.9%. GAAP EPS was $0.15 vs $0.05, and adjusted EBITDA was $6.1 million vs $4.1 million. Backlog rose to $117.5 million.
How this was made
The 30-second read
Why it matters
Q2 results show YoY revenue down slightly, but profitability improved materially: gross margin rose to 28.9% (26.6% excluding the IEEPA refund), GAAP EPS increased to $0.15, and adjusted EBITDA rose to $6.1M. Backlog reached $117.5M, the highest in company history, which can support future production and revenue conversion.
Market read
Traders can reassess ULBI’s earnings trajectory using the fresh margin, EPS, adjusted EBITDA, and record backlog figures, plus segment-level growth and cost drivers.
What to watch
Operating expenses rose due to new product development and one-time litigation/consulting costs, so investors may need to separate sustainable margin gains from temporary cost and tariff effects.
Background
Ultralife operates two segments, Battery & Energy Products and Communications Systems, and is executing manufacturing-efficiency initiatives plus new product development for government/defense programs.
Ticker impact
Ultralife reported Q2 revenue of $47.9M, GAAP EPS $0.15, and gross margin up to 28.9% with backlog hitting a record $117.5M.
Likely positive bias for ULBI on earnings-day positioning, with follow-through dependent on whether investors focus on margin quality and backlog conversion.
The release provides multiple fresh datapoints (GAAP EPS, gross margin ex-refund, adjusted EBITDA, and record backlog) that can re-rate expectations, though the top-line decline tempers the signal.
Market effects
Signals improving profitability in defense-linked communications and battery systems, potentially supportive for small-cap defense electronics sentiment.
Limited direct regional spillover; primarily company-specific.
References government/defense programs and international operations, but no new global macro or policy shock beyond tariff/refund context.
Counterpoint
Gross margin improvement is partly attributed to a net IEEPA refund; if that benefit is non-recurring, the earnings power may be overstated.
Key entities
- companyUltralife Corporation
NASDAQ-listed company reporting Q2 2026 results, margin improvement initiatives, and record backlog.
- business_segmentCommunications Systems segment
Reported 39.3% YoY revenue growth to $3.8M and higher gross margin driven by sales mix.
- business_segmentBattery & Energy Products segment
Reported revenue decline to $44.2M but improved gross margin to 28.3% aided by favorable mix and IEEPA refund.
